MedTrace Logo

Registry Platform Myelofibrosis and Anemia

NCT06976918 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-03-30

No results posted yet for this study

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease and to collect patient-reported outcomes for patients with primary and secondary myelofibrosis and anemia in Germany.

Conditions

  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Post-essential Thrombocythemia Myelofibrosis
  • Anemia
  • Myelofibrosis; Anemia
  • Myelofibrosis

Sponsors & Collaborators

  • German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

    collaborator UNKNOWN

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Konstanze Döhner, Prof. Dr. med. · University Hospital Ulm, Germany

  • Steffen Koschmieder, Prof. Dr. med. · University Hospital Aachen, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-19
Primary Completion
2031-09-30
Completion
2031-09-30

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06976918 on ClinicalTrials.gov